LZAP inhibits p38 MAPK (p38) phosphorylation and activity by facilitating p38 association with the wild- type p53 Induced phosphatase 1 (WIP1)

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  An, Hanbing ^a   Lu, Xinyuan ^a,b   Liu, Dan ^a,b   Yarbrough, Wendell G ^a,b,c  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN LZAP; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; WILD TYPE P53 INDUCED PHOSPHATASE 1; CDK5RAP3 PROTEIN, HUMAN; NERVE PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2C; PROTEIN P53; SIGNAL PEPTIDE;

ARTICLE; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; GENE MUTATION; MAMMAL CELL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEINASE INHIBITION; WILD TYPE; CELL COMPARTMENTALIZATION; DRUG ANTAGONISM; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

CELL COMPARTMENTATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NERVE TISSUE PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PROTEIN BINDING; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 79551542335     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016427     Document Type: Article

References (41)

1. Ching YP, Qi Z, Wang JH (2000) Cloning of three novel neuronal Cdk5 activator binding proteins. Gene 242: 285-294.
2. Wang J, He X, Luo Y, Yarbrough WG (2006) A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2. Biochem J 393: 489-501.
3. Wang J, An H, Mayo MW, Baldwin AS, Yarbrough WG (2007) LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB. Cancer Cell 12: 239-251.
4. Jiang H, Luo S, Li H (2005) Cdk5 activator-binding protein C53 regulates apoptosis induced by genotoxic stress via modulating the G2/M DNA damage checkpoint. J Biol Chem 280: 20651-20659.
5. Jiang H, Wu J, He C, Yang W, Li H (2009) Tumor suppressor protein C53 antagonizes checkpoint kinases to promote cyclin-dependent kinase 1 activation. Cell Res 19: 458-468.
6. Wu J, Lei G, Mei M, Tang Y, Li H (2010) A novel C53/LZAP-interacting protein regulates stability of C53/LZAP and DDRGK domain-containing Protein 1 (DDRGK1) and modulates NF-kappaB signaling. J Biol Chem 285: 15126-15136.
7. Kwon J, Cho HJ, Han SH, No JG, Kwon JY, et al. (2010) A novel LZAPbinding protein, NLBP, inhibits cell invasion. J Biol Chem 285: 12232-12240.
8. Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-549.
9. Cuenda A, Rousseau S (2007) p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 1773: 1358-1375.
10. Takekawa M, Adachi M, Nakahata A, Nakayama I, Itoh F, et al. (2000) p53- inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. Embo J 19: 6517-6526.
11. Zarubin T, Han J (2005) Activation and signaling of the p38 MAP kinase pathway. Cell Res 15: 11-18.
12. Thornton TM, Rincon M (2009) Non-classical p38 map kinase functions: cell cycle checkpoints and survival. Int J Biol Sci 5: 44-51.
13. Bulavin DV, Fornace AJ, Jr. (2004) p38 MAP kinase's emerging role as a tumor suppressor. Adv Cancer Res 92: 95-118.
14. Ghatan S, Larner S, Kinoshita Y, Hetman M, Patel L, et al. (2000) p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J Cell Biol 150: 335-347.
15. Ishikawa Y, Kusaka E, Enokido Y, Ikeuchi T, Hatanaka H (2003) Regulation of Bax translocation through phosphorylation at Ser-70 of Bcl-2 by MAP kinase in NO-induced neuronal apoptosis. Mol Cell Neurosci 24: 451-459.
16. Esteva FJ, Sahin AA, Smith TL, Yang Y, Pusztai L, et al. (2004) Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma. Cancer 100: 499-506.
17. Junttila MR, Ala-Aho R, Jokilehto T, Peltonen J, Kallajoki M, et al. (2007) p38alpha and p38delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells. Oncogene 26: 5267-5279.
18. Greenberg AK, Basu S, Hu J, Yie TA, Tchou-Wong KM, et al. (2002) Selective p38 activation in human non-small cell lung cancer. Am J Respir Cell Mol Biol 26: 558-564.
19. Pomerance M, Quillard J, Chantoux F, Young J, Blondeau JP (2006) High-level expression, activation, and subcellular localization of p38-MAP kinase in thyroid neoplasms. J Pathol 209: 298-306.
20. Obenauer JC, Cantley LC, Yaffe MB (2003) Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 31: 3635-3641.
21. Mayor F, Jr., Jurado-Pueyo M, Campos PM, Murga C (2007) Interfering with MAP kinase docking interactions: implications and perspective for the p38 route. Cell Cycle 6: 528-533.
22. Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, et al. (1999) Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. Embo J 18: 6845-6854.
23. Corti O, Hampe C, Koutnikova H, Darios F, Jacquier S, et al. (2003) The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum Mol Genet 12: 1427-1437.
24. Spaziani A, Alisi A, Sanna D, Balsano C (2006) Role of p38 MAPK and RNAdependent protein kinase (PKR) in hepatitis C virus core-dependent nuclear delocalization of cyclin B1. J Biol Chem 281: 10983-10989.
25. Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J (1996) Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 271: 20608-20616.
26. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davis RJ (1996) MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 16: 1247-1255.
27. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, et al. (1995) Proinflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270: 7420-7426.
28. Fu J, Yang Z, Wei J, Han J, Gu J (2006) Nuclear protein NP60 regulates p38 MAPK activity. J Cell Sci 119: 115-123.
29. Lu X, Ma O, Nguyen TA, Jones SN, Oren M, et al. (2007) The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. Cancer Cell 12: 342-354.
30. Bulavin DV, Amundson SA, Fornace AJ (2002) p38 and Chk1 kinases: different conductors for the G(2)/M checkpoint symphony. Curr Opin Genet Dev 12: 92-97.
31. Lu X, Nannenga B, Donehower LA (2005) PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev 19: 1162-1174.
32. Bulavin DV, Phillips C, Nannenga B, Timofeev O, Donehower LA, et al. (2004) Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat Genet 36: 343-350.
33. Fiscella M, Zhang H, Fan S, Sakaguchi K, Shen S, et al. (1997) Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci U S A 94: 6048-6053.
34. Xia Y, Ongusaha P, Lee SW, Liou YC (2009) Loss of Wip1 sensitizes cells to stress- and DNA damage-induced apoptosis. J Biol Chem 284: 17428-17437.
35. Chew J, Biswas S, Shreeram S, Humaidi M, Wong ET, et al. (2009) WIP1 phosphatase is a negative regulator of NF-kappaB signalling. Nat Cell Biol 11: 659-666.
36. Fujimoto H, Onishi N, Kato N, Takekawa M, Xu XZ, et al. (2006) Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase. Cell Death Differ 13: 1170-1180.
37. Lu X, Bocangel D, Nannenga B, Yamaguchi H, Appella E, et al. (2004) The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair. Mol Cell 15: 621-634.
38. Zhang Y, Xiong Y, Yarbrough WG (1998) ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92: 725-734.
39. Yarbrough WG, Bessho M, Zanation A, Bisi JE, Xiong Y (2002) Human tumor suppressor ARF impedes S-phase progression independent of p53. Cancer Res 62: 1171-1177.
40. Zhang Y, Xiong Y (1999) Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol Cell 3: 579-591.
41. Abdelmohsen K, Pullmann R, Jr., Lal A, Kim HH, Galban S, et al. (2007) Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell 25: 543-557.